Biotech China 2014

View Profile


Speaking/Presenting-Abstract/Poster at Mtg

Topic Authors / presenters Event name Event date
1. Immunogene Therapy Lichtor T, Glick RP Adv Exp Med Biol 2012; 746: 151-165 January, 2012
2. Evolution of the Molecular Biology of Brain Tumors and the Therapeutic Implications Terry Lichtor Rijeka, Croatia: InTech, 2012, (In Press). January, 2012
3. Immunogene Therapy Lichtor T, Glick RP In: Glioma: Immunotherapeutic Approaches (Ryuya Yamanaka, ed). Austin, Texas: Landes Bioscience and Springer Science, 2012, pates 151-165 January, 2012
4. Brain Tumor Immunology and Immunotherapy Glick RP, Lichtor T, Heimberger AB In: Youmans Neurological Surgery, 6th Edition (H Richard Winn, ed). Philadelphia, Pennsylvania: Elsevier Saunders, 2011, pages 1087-1101 January, 2011
5. Development of a DNA-Based Vaccine for Treatment of an Intracerebral Tumor. Lichtor T, Glick R In: Brain Tumors. Current and Emerging Therapeutic Strategies. (Ana Lucia Abujamra, ed). Rijeka, Croatia: InTech, 2011, pages 389-402 January, 2011
6. Development of a DNA-Based Vaccine for Treatment of Intracerebral Breast Cancer Lichtor T Trends in Cancer Research 2010; 6: 15-24 January, 2010
7. Brain Tumor Immunotherapy Lichtor T The Open Cancer Immunology Journal 2010; 3: 22. January, 2010
8. Treatment of Brain Tumors Using DNA-Based Vaccines Lichtor T The Open Cancer Immunology Journal 2010; 3: 23-29 January, 2010
9. PPAR-γ Thiazolidinedione Agonists and Immunotherapy in the Treatment of Brain Tumors Lichtor T, Spagnolo A, Glick RP, Feinstein DL PPAR Research 2008; 2008: Article ID 547470, pages 1-4. January, 2008
10. Immunobiology and Immune Therapy Glick RP, Lichtor T In: Neuro-Oncology: The Essentials, 2nd Edition (M Bernstein and MS Berger, eds). New York, New York: Thieme Medical Publishers, 2008, pages 214-223 January, 2008
11. Cytokine Immuno-Gene Therapy for Immunotherapy for Malignant Brain Tumors Glick RP, Lichtor T, Lin H, Cohen EP In: Current Clinical Oncology: High- Grade Gliomas: Diagnosis and Treatment (GH Barnett, ed). Totowa, New Jersey: The Humana Press Inc, 2007, pages 357-372 January, 2007
12. From Cerebrospinal Fluid Pulsation to Noninvasive Intracranial Compliance and Pressure Measured by MRI Flow Studies Alperin N, Mazda M, Lichtor T, Lee SH Current Medical Imaging Reviews 2006; 2: 117-129 January, 2006
13. Antigenic Differences Between Normal and Malignant Cells as a Basis for Treatment of Intracerebral Neoplasms Using a DNA- Based Vaccine Lichtor T, Glick RP, O-Sullivan I, Cohen EP Current Genomics 2006; 7: 253-261 January, 2006
14. DNA-Based Vaccine for Treatment of Intracerebral Neoplasms Lichtor T, Glick RP, O-Sullivan I, Cohen EP Gene Therapy and Molecular Biology 2004; 8: 395-402 January, 2004
15. Approaches to the Treatment of Brain Tumors Using Cytokine-Secreting Allogeneic Fibroblasts Lichtor T, Glick RP, Cohen EP Cancer Therapy 2003; 1: 109-120. January, 2003
16. Triage and Management of Neurosurgical Emergencies Stone JL, Lichtor T In: Textbook of Neurological Surgery: Principles and Practice (HH Batjer and CM Loftus, eds). Philadelphia, Pennsylvania: Lippincott Williams & Wilkins Publishers, 2003, pages 754-763 January, 2003
17. Cytokine Immuno-Gene Therapy for Treatment of Brain Tumors Lichtor T, Glick RP Journal of Neuro-Oncology 2003; 65: 247-259 January, 2003
18. Long-lasting Changes in Blood and CSF Flow Dynamics Following Mild Traumatic Brain Injury Alperin N, Varadarajalu B, Fisher C, Lichtor T Proceedings of the International Society for Magnetic Resonance in Medicine 2002; 2: 128 January, 2002
19. Tumor Vaccine Strategies Using Allogeneic IL-2- Secreting Fibroblasts in the Treatment of CNS Tumors Lichtor T, Glick RP, Cohen EP Proceedings of the American Association for Cancer Research 2002; 43: 1111 January, 2002
20. Immunotherapy Task Force for Malignant Brain Tumors Glick RP, Lichtor T Toronto, Ontario. Neuro-Oncology 2001; 3: 258-264 April, 2001
21. Chapter on ‘Fingerprints of EMC flavor compounds by GC/MS and Pyrolysis/GC/MS’ LEE, B.H., Haileselassie, S., Stewart, B. and Yaylayan, V Royal Society of Chemistry, London, pp. 141-150. January, 2001
22. Cytokine-Based Immuno-Gene Therapy for Brain Tumors. Glick RP, Lichtor T, Cohen EP In: Brain Tumor Immunotherapy (LM Liau, DP Becker, TF Cloughesy, DD Bigner, eds). Totowa, New Jersey: Humana Press Inc, 2001, pages 273-288 January, 2001
23. Immunotherapy for Tumors Task Force Holds Inaugural Meeting Glick RP, Lichtor T American Association of Neurological Surgeons Bulletin 2001; 10: 35-37 January, 2001
24. LEE, B.H Fundamentos de Biotecnologia de los Alimentos, p.448, Acribia, Zaragoza January, 2000
25. Decreased EGFR Expression and Growth of the Human Derived T98G Glioblastoma Following Treatment with Anti-Sense Oligonucleotides Directed Against EGFR. Rubenstein M, Glick R, Lichtor T, Mirochnik Y, Guinan P Proceedings of the American Association for Cancer Research 2000; 41: 644 January, 2000
26. Novel Therapeutic Strategies for Central Nervous System Tumors. Glick RP, Lichtor T In: Neuro-Oncology: The Essentials (M Bernstein and MS Berger, eds). New York, New York: Thieme Medical Publishers, 2000, pages 289-300. January, 2000
27. Cytokine Immunogene Therapy Glick RP, Lichtor T, Cohen EP Neurosurgical Focus 2000; 9 (6): Article 2, 1-9 January, 2000
28. Determination of Intracranial Pressure from MRI Measurements of Blood and CSF Volumetric Flow Rates Alperin N, Loth F, Stelzig C, Lee S, Charbel F, Lichtor T Proceedings of the European Society for Magnetic Resonance in Medicine and Biology 1999; Vol. 8 Supplement 1, p89 January, 1999
29. Establishment of the T98G Glioblastoma Tumor in Athymic Nude Mice Utilizing Matrigel and Orthotopic Implantation Rubenstein M, Shaw MW, Slobodskoy L, Mirochnik Y, Glick R, Lichtor T, Shaw MM, Robertson N, Garcia V, Frazier L, Guinan P Proceedings of the American Association for Cancer Research 1999; 40: 717 January, 1999
30. Does CSF Flow Dynamics Characterize the Mechanical State of the CranioSpinal System? Alperin N, Stelzig C, Betz W, Charbel F, Lichtor T Proceedings of the Society for Magnetic Resonance in Medicine 1999; 3: 2011. January, 1999
31. Method for non-invasive measurements of ICP Alperin N, Loth F, Betz W, Lichtor T Second Congress of the International Society for Neurosurgical Instrument Inventors 1999; ISNTII, p38 January, 1999
32. Dose response and cellular uptake of antisense oligonucleotides to transforming growth factor- and the epidermal growth factor receptor of the T98G glioblastoma Rubenstein M, Glick R, Lichtor T, Mirochnik Y, Guinan P Proceedings of the American Association for Cancer Research 1998; 39: 416 January, 1998
33. Treatment of the T98G glioblastoma cell line with antisense oligonucleotides directed towards mRNA encoding transforming growth factor- and the epidermal growth factor receptor Rubenstein M, Glick R, Lichtor T, Mirochnik Y, Guinan P Proceedings of the American Association for Cancer Research 1997; 38: 10. January, 1997
34. Insulin-Like Growth Factors in Central Nervous System Tumors Glick RP, Lichtor T, Unterman TG J of Neuro-Oncology 1997; 35: 315-325. January, 1997
35. LEE, B. H Fundamentals of Food Biotechnology, 450 p.,VCH Publishers, New York January, 1996
36. An Allogeneic Tumor Vaccine Fails to Survive in the CNS. Glick RP, Griffitt W, Lichtor T, Cohen EP Proceedings of the American Association for Cancer Research 1996; 37: 341 January, 1996
37. Patients with Glasgow Coma Scores 3,4,5 After Gunshot Wounds tothe Brain Kaufman HH, Levy ML, Stone JL, Masri LS, Lichtor T, Lavine SD, Fitzgerald LF, Apuzzo MLJ Neurosurgery Clinics of North America 1995; 6: 701-714 January, 1995
38. Chapter on “Galactooligo-saccharides production by immobilized ß-galactosidases from Thermus aquaticus YT-1”. Berger, J. L., LEE, B. H. and Lacroix, C. In: Proceedings of New Developments of Bioencapsulation for Industrial Applications, Food, Beverage and Health, pp. 55-60, Laval University, Quebec January, 1994
39. Functional Electrical Stimulation for Ambulation Lichtor T Krieger Publishing Company, Malabar, Florida, 1994. Chicago Medicine 1995; 98: 22 January, 1994
40. Radiosurgery Lichtor T, Stone JL Baseline and Trends, edited by Ladislau Steiner. Ravin Press, New York, New York, 1991. Chicago Medicine 1993; 96: 34-35 January, 1993
41. Gene Expression of Cytokines and Neurotrophic Factors in Human Brain Tumors Lichtor T, Gurney ME Methods in Neurosciences 1992; 9: 32-46 January, 1992
42. Chapter on "Genetic Engineering; Enzyme Cloning" LEE, B. H Encyclopedia of Food Science & Technology" (Editor-In-Chief, Y.H. Hui), pp. 1601-1616, John Wiley & Sons, Inc January, 1991
43. Chapter on "Bioconversion of starch wastes" LEE, B. H Bioconversion of Waste Materials to Industrial Products" (Editor, A.M. Martin), pp. 521-531, Elsevier Publ. Co., UK. January, 1991
44. Chapter on "Single Cell Protein" LEE, B. H Centre Québécois de valorisation de la biomasse (C.Q.V.B.), Quebec, pp. 40-51 January, 1988
45. The Effects of Surgical Sympathectomy in Experimental Atherosclerosis. Vesselinovitch D, Lichtor T, Bridenstine RT, Mullan S In: Biology of the Arterial Wall;Interaction of the Arterial Wall and Atherosclerosis. Rome: CIC Edizioni Internazionali, 1988, pages 159-166. January, 1988
46. Patients with Lipoprotein Disorders. Lichtor JL, Ward J, Lichtor T Anesthesiology Clinics of North America 1987; 5: 299-312 January, 1987
47. Cytoplasmic Inheritance of Rutamycin Resistance and a Respiratory Deficiency in Mouse Fibroblasts Lichtor T Chicago, Illinois: The Universiy of Chicago, 1980. 115 p January, 1980
48. Cytoplasmic Inheritance of Rutamycin Resistance in Mouse Fibroblasts Lichtor T, Getz GS Federation Proceedings 1977; 36: 859 January, 1977



Site wide Speaking/Presenting-Abstract/Poster at Mtg

Presentation Event Month, Year
Track 4: Neurosurgery International Conference and Exhibition on Surgery & Transplantation November, 2012

4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.